Evidence map›Paper›PMID 36230628›Full record

ArticleCancers2022

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.

Virginia Lope, Angel Guerrero-Zotano, Emma Ruiz-Moreno, Begoña Bermejo, Silvia Antolín, Álvaro Montaño, José Manuel Baena-Cañada, Manuel Ramos Vázquez, Nerea Fernández de Larrea-Baz, José Ignacio Chacón and 18 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04379908 (Healthy Lifestyles and Quality of Life in Women With Breast Cancer), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04379908 completednot on this map

Healthy Lifestyles and Quality of Life in Women With Breast Cancer (Health-EpiGEICAM)

Typeobservational_patient_registrySponsorSpanish Breast Cancer Research GroupRan2017 to 2019Enrolled801ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The impact of multimodal high intensity exercise program comparing online and onsite interventions in breast cancer survivors: a randomized controlled trial.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Trial
  3. Impact of lung cancer diagnosis on patient lifestyle and physical activity.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Virginia LopeDepartment of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-6986-4021
Angel Guerrero-ZotanoGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Emma Ruiz-MorenoDepartment of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0003-3662-4440
Begoña BermejoGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Silvia AntolínGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Álvaro MontañoGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
José Manuel Baena-CañadaGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.ORCID 0000-0002-8403-9804
Manuel Ramos VázquezGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.ORCID 0000-0001-7264-8234
Nerea Fernández de Larrea-BazDepartment of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos 5, 28029 Madrid, Spain.
José Ignacio ChacónGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
José Angel García-SáenzGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Clara OlierGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Montserrat MuñozGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Antonio AntónGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.ORCID 0000-0002-2802-6232
Pedro Sánchez RoviraGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Angels Arcusa LanzaGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Sonia GonzálezGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Amparo OltraGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Joan BrunetGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.ORCID 0000-0003-1945-3512
Joaquín Gavilá GregoriGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
María Teresa MartínezGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Lourdes CalvoGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Libertad RosellGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Susana BezaresGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Roberto Pastor-BarriusoDepartment of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos 5, 28029 Madrid, Spain.
Beatriz Pérez-GómezDepartment of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos 5, 28029 Madrid, Spain.ORCID 0000-0002-4299-8214
Miguel MartínGEICAM Spanish Breast Cancer Group, Scientific Department, 28703 Madrid, Spain.
Marina PollánDepartment of Epidemiology of Chronic Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, Avda. Monforte de Lemos 5, 28029 Madrid, Spain.

Funding

Fundación Científica Asociación Española Contra el Cancer AECC 2016
6 · The paper itself

Abstract

Breast cancer (BC) survivors are advised to follow the WCRF/AICR cancer prevention recommendations, given their high risk of developing a second tumour. We aimed to explore compliance with these recommendations in BC survivors and to identify potentially associated clinical and sociodemographic factors. A total of 420 BC survivors, aged 31-80, was recruited from 16 Spanish hospitals. Epidemiological, dietary and physical activity information was collected through questionnaires. A 7-item score to measure compliance with the recommendations was built according to the 2018 WCRF/AICR scoring criteria. Standardized prevalences and standardized prevalence ratios of moderate and high compliance across participant characteristics were estimated using multinomial and binary logistic regression models. The mean score was 3.9 (SD: 1.0) out of 7 points. Recommendations with the worst adherence were those of limiting consumption of red/processed meats (12% of compliance, 95% CI: 8.2-15.0) and high fibre intake (22% of compliance, 95% CI: 17.6-27.0), while the best compliance was observed for the consumption of fruits and vegetables (73% of compliance, 95% CI: 69.2-77.7). Overall, adherence was worse in women with university education and in those with first-degree relatives with BC. This information may be of interest to design and implement personalized preventive measures adapted to the characteristics of these patients.

Indexed as

breast cancercancer prevention recommendationscompliancehealth behavioursHealth-EpiGEICAMhealthy lifestylelifestyle recommendationssurvivalWCRF/AICR guidelines

Identifiers

PMID36230628
PMCPMC9561971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.